Home

The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patientsí quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Groupís ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).

SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.


Visitors and news

New publication: Delivering colorectal cancer screening integrated to primary health care services in Morocco: lessons learnt from a demonstration project

07/01/2022
Authors of this article published in Cancer journal, described the performance of the colorectal cancer (CRC) screening with faecal immunochemical test offered through existing health infrastructure in Morocco. The study also highlighted facilitators and challenges that must be considered before making any decision to introduce CRC screening in Morocco and resource-constrained settings in general.
View the article.

Cervical cancer awareness month: CBIG-SCREEN project

06/01/2022
During January, the cervical cancer awareness month, the CBIG-SCREEN project will be posting short videos to introduce the project. Here you can watch the first, with the project coordinator, Marc Bardou.
View the video and visit the project website.

January is cervical cancer awareness month!

04/01/2022
Throughout January, the International Agency for Research on Cancer (IARC) will mark Cervical Cancer Awareness Month with a series of posts, including tweets, interviews, and infographics. Stay tuned to the IARC website, www.iarc.fr, the IARC Twitter account, @IARCWHO, and the IARC YouTube channel, IARC WHO, during January to learn more about cervical cancer and the worldwide initiative to eliminate this disease as a public health problem. Read the IARC news

New release (December) of the CanScreen5 platform with new country data

31/12/2021
The CanScreen5 IARC Secretariat, following support of country collaborators and validation by our scientific committee, is happy to announce the availability on the CanScreen5 platform of the following country factsheets: Cameroon, and South Africa.
Visit the CanScreen5 website to explore characteristics and performance of cancer screening programmes across the globe in more than 67 countries.

New publication: Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer

13/12/2021
This article published in PrevMed Journal, summarizes an expert advisory group convened by WHO to identify priority implementation research questions for HPV-based screening and treatment interventions in population-based programmes. for countries towards elimination of cervical cancer. Answering these questions could provide actionable guidance for countries towards elimination.
View the article.

All visitors and news


Scientific papers

Selmouni F., Amrani L., Sauvaget C., Bakkar M., El Khannoussi B., Souadka A., Benkabbou A., Majbar M.A., Belekhel L., Lucas E., Muwonge R., Chami Khazraji Y., Mohsine R., Bennani M., Sankaranarayanan R., Bekkali R., Basu P. Delivering colorectal cancer screening integrated with primary health care services in Morocco: Lessons learned from a demonstration project. Cancer. 2022 Jan 5.
PMID: 34985785
Basu P., Muwonge R. Alternative analysis of the data from a HPV vaccine study in India - Authors' reply. Lancet Oncol. 2022 Jan;23(1):e10.
PMID: 34973220
Broutet N., Jeronimo J., Kumar S., Almonte M., Murillo R., Huy N.V.Q., Denny L., Kapambwe S., Bhatla N., Sebitloane M., Zhao F., Gravitt P., Adsul P., Rangaraj A., Dalal S., Newman M., Chowdhury R., Church K., Nakisige C., Diop M., Parham G., Thomson K.A., Basu P., Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 8;106906.
PMID: 34896155

All scientific papers

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2022 - Terms of use  -  Privacy Policy.